{{Rsnum
|rsid=10985375
|Gene=DAB2IP
|Chromosome=9
|position=121787363
|Orientation=plus
|GMAF=0.1492
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 3.2 | 22.6 | 74.2
| HCB | 4.8 | 14.3 | 81.0
| JPT | 0.0 | 23.3 | 76.7
| YRI | 0.0 | 16.7 | 83.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.8 | 14.3 | 81.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=2E-6
  |OR=33.94
  |ORtxt=[19.81-48.07] mg/dL decrease
  |OA=1
}}